Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000567707

Apexbio Technology LLC Anti-Nectin-4-Ab-Enfortumab
SDP

Catalog No. 5000567707
Encompass_Preferred

Anti-Nectin-4 Antibody (Enfortumab) (CAS No 1448664-46-7) is a therapeutic monoclonal antibody used in biomedical research focused on targeted cancer therapy It originates from studies advancing the treatment of tumors expressing Nectin-4 a protein overexpressed in various cancers including urothelial carcinoma The mechanism of action involves binding to Nectin-4 leading to the disruption of signaling pathways essential for tumor growth and survival Its in vitro activity is characterized within the nanomolar to low micromolar range effectively inhibiting tumor cell proliferation This antibody is widely used in cell models and animal studies to explore its therapeutic potential and efficacy It also plays a significant role in drug screening processes to evaluate novel cancer treatments Experimental concentrations typically depend on the specific research design enabling flexibility in adapting to different experimental requirements

Catalog No. 50-005-67707 Supplier Apexbio Technology LLC Supplier No. F209750
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Anti-Nectin-4 Antibody (Enfortumab) (CAS No 1448664-46-7) is a therapeutic monoclonal antibody used in biomedical research focused on targeted cancer therapy It originates from studies advancing the treatment of tumors expressing Nectin-4 a protein overexpressed in various cancers including urothelial carcinoma The mechanism of action involves binding to Nectin-4 leading to the disruption of signaling pathways essential for tumor growth and survival Its in vitro activity is characterized within the nanomolar to low micromolar range effectively inhibiting tumor cell proliferation This antibody is widely used in cell models and animal studies to explore its therapeutic potential and efficacy It also plays a significant role in drug screening processes to evaluate novel cancer treatments Experimental concentrations typically depend on the specific research design enabling flexibility in adapting to different experimental requirements

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.